The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D11 | Other dermatological preparations | |
| 3 | D11A | Other dermatological preparations | |
| 4 | D11AH | Agents for dermatitis, excluding corticosteroids | |
| 5 | D11AH11 |
| Active Ingredient | Description | |
|---|---|---|
| Delgocitinib |
Delgocitinib is a pan Janus kinase (JAK) inhibitor that targets the activity of all four members of the JAK family of enzymes consisting of JAK1, JAK2, JAK3, and tyrosine kinase 2 (TYK2) in a concentration dependent manner. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ANZUPGO Cream | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.